Cargando…

A pantothenate suxotroph of BCG rxpressing Gag confers enhanced HIV-specific immunogenicity compared to wildtype and perfingolysin expressing strains

Detalles Bibliográficos
Autores principales:	Chetty, S, Shephard, E, Bowers, D, Darby, M, Horsnell, W, Chapman, R, Williamson, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441340/ http://dx.doi.org/10.1186/1742-4690-9-S2-P315

Ejemplares similares

Priming with a Recombinant Pantothenate Auxotroph of Mycobacterium bovis BCG and Boosting with MVA Elicits HIV-1 Gag Specific CD8(+) T Cells
por: Chapman, Rosamund, et al.
Publicado: (2012)

The Use of Directed Evolution to Create a Stable and Immunogenic Recombinant BCG Expressing a Modified HIV-1 Gag Antigen
por: Chapman, Rosamund, et al.
Publicado: (2014)

A prime-boost immunization with rBCG expressing HIV-1 Gag, RT and gp120 and SAAVI MVA-C elicits immune responses in blood and MALT of rhesus macaques
por: Chege, GK, et al.
Publicado: (2012)

Priming with Recombinant Auxotrophic BCG Expressing HIV-1 Gag, RT and Gp120 and Boosting with Recombinant MVA Induces a Robust T Cell Response in Mice
por: Chapman, Rosamund, et al.
Publicado: (2013)

Correction: Priming with Recombinant Auxotrophic BCG Expressing HIV-1 Gag, RT and Gp120 and Boosting with Recombinant MVA Induces a Robust T Cell Response in Mice
por: Chapman, Rosamund, et al.
Publicado: (2013)

HIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in Mice
por: Jongwe, Tsungai Ivai, et al.
Publicado: (2016)

P19-53 LB. Priming with recombinant BCG expressing HIV-1 Gag or RT and boosting with recombinant MVA induces an effective immune response in mice
por: Stutz, H, et al.
Publicado: (2009)

Mutations in the pantothenate kinase of Plasmodium falciparum confer diverse sensitivity profiles to antiplasmodial pantothenate analogues
por: Tjhin, Erick T., et al.
Publicado: (2018)

Abrogation of contaminating RNA activity in HIV-1 Gag VLPs
por: Valley-Omar, Ziyaad, et al.
Publicado: (2011)

Induction of HIV-1 Gag-specific memory T cells in Chacma baboons by MVA prime and VLP boost vaccine regimen
por: Singh, V, et al.
Publicado: (2012)

Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles
por: Chapman, Rosamund, et al.
Publicado: (2020)

Compartmentalization of Mammalian Pantothenate Kinases
por: Alfonso-Pecchio, Adolfo, et al.
Publicado: (2012)

Pantothenate kinase-associated neurodegeneration
por: Hundallah, Khalid, et al.
Publicado: (2017)

The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma
por: Diplas, Bill H., et al.
Publicado: (2018)

Heterologous prime-boost vaccination with DNA and MVA vaccines, expressing HIV-1 subtype C mosaic Gag virus-like particles, is highly immunogenic in mice
por: Chapman, Ros, et al.
Publicado: (2017)

THE EFFECTS OF PANTOTHENIC ACID ON RESPIRATORY ACTIVITY
por: Pratt, Ernest F., et al.
Publicado: (1939)

Genetic mutation spectrum of pantothenate kinase-associated neurodegeneration expanded by breakpoint sequencing in pantothenate kinase 2 gene
por: Yang, Dahae, et al.
Publicado: (2022)

Immune responses against SARS-CoV-2 wildtype in unvaccinated patients with high-risk NMIBC undergoing intravesical BCG therapy
por: Pichler, R., et al.
Publicado: (2023)

New insights into retroviral Gag–Gag and Gag–membrane interactions
por: Maldonado, José O., et al.
Publicado: (2014)

Pantothenate kinase-associated neurodegeneration is not a synucleinopathy
por: Li, A, et al.
Publicado: (2013)

Novel pantothenate derivatives for anti-malarial chemotherapy
por: Pett, Helmi E, et al.
Publicado: (2015)

Precision medicine in pantothenate kinase-associated neurodegeneration
por: Álvarez-Córdoba, Mónica, et al.
Publicado: (2019)

Proposed Therapies for Pantothenate-Kinase-Associated Neurodegeneration
por: Jackowski, Suzanne
Publicado: (2019)

Redesigning therapies for pantothenate kinase–associated neurodegeneration
por: Munshi, Muhammad I., et al.
Publicado: (2022)

Reducing the Activity and Secretion of Microbial Antioxidants Enhances the Immunogenicity of BCG
por: Sadagopal, Shanmugalakshmi, et al.
Publicado: (2009)

Use of the piggyBac transposon to create HIV-1 gag transgenic insect cell lines for continuous VLP production
por: Lynch, Alisson G, et al.
Publicado: (2010)

Novel Compound Heterozygous Mutations in the Pantothenate Kinase 2 Gene in a Korean Patient with Atypical Pantothenate Kinase Associated Neurodegeneration
por: Kim, Sung-Hyouk, et al.
Publicado: (2009)

Updates in IDH-Wildtype Glioblastoma
por: Melhem, Jawad M., et al.
Publicado: (2022)

Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques
por: White, A. D., et al.
Publicado: (2015)

The Influence of Thiamine and Pantothenate Upon Tissue -Sh Levels
por: Calcutt, G.
Publicado: (1961)

The Pathogenesis of Duodenal Ulcer Disease in the Pantothenate-Deficient Rat
por: Seronde, Joseph
Publicado: (1963)

Late Onset Atypical Pantothenate-Kinase-Associated Neurodegeneration
por: Diaz, Natalie
Publicado: (2013)

Deep Brain Stimulation for Pantothenate Kinase-Associated Neurodegeneration
por: Garcia-Ruiz, Pedro J., et al.
Publicado: (2015)

A therapeutic approach to pantothenate kinase associated neurodegeneration
por: Sharma, Lalit Kumar, et al.
Publicado: (2018)

Eye of the Tiger Sign in Pantothenate Kinase-Associated Neurodegeneration
por: Choayb, S., et al.
Publicado: (2021)

Pantothenate Auxotrophy in a Naturally Occurring Biocontrol Yeast
por: Rueda-Mejia, Maria Paula, et al.
Publicado: (2023)

BCGΔBCG1419c increased memory CD8(+) T cell-associated immunogenicity and mitigated pulmonary inflammation compared with BCG in a model of chronic tuberculosis
por: Kwon, Kee Woong, et al.
Publicado: (2022)

Gag-Gag Interactions Are Insufficient to Fully Stabilize and Order the Immature HIV Gag Lattice
por: Saha, Ipsita, et al.
Publicado: (2021)

Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2009)

Oral vaccination with a recombinant Salmonella vaccine vector provokes systemic HIV-1 subtype C Gag-specific CD4+ Th1 and Th2 cell immune responses in mice
por: Chin'ombe, Nyasha, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_chfh2eogjh8ij1dd40l2c4inj9